What The FDA Gave Clovis Oncology In June 2013, It Has Taken Away

By: via Benzinga
Clovis Oncology Inc (NASDAQ: CLVS) shares are trading lower lower by $67 at $32.43 in Monday's session. The catalyst for the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.